表紙:サイトメガロウイルス (CMV) 網膜炎:世界の治験動向
市場調査レポート
商品コード
319596

サイトメガロウイルス (CMV) 網膜炎:世界の治験動向

Cytomegalovirus (CMV) Retinitis Global Clinical Trials Review, H1, 2019

出版日: | 発行: GlobalData | ページ情報: 英文 59 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=115.11円
サイトメガロウイルス (CMV) 網膜炎:世界の治験動向
出版日: 2019年04月30日
発行: GlobalData
ページ情報: 英文 59 Pages
納期: 即納可能 即納可能とは
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、サイトメガロウイルス (CMV) 網膜炎の治験に関連する基本情報やデータを提供しており、試験件数および被験者の募集状況、段階別の動向、治験を実施している主な製薬企業および研究機関のプロファイルなどをまとめています。

当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • 主要国における治験件数:アジア太平洋地域
    • 主要国における治験件数:欧州
    • 主要国における治験件数:北米
    • 主要国における治験件数:中東/アフリカ地域

G7諸国における治験件数:サイトメガロウイルス (CMV) 網膜炎 治験件数の感染症治験件数に対する比率

フェーズ (相) 別治験件数:G7諸国

G7諸国における治験件数:フェーズ (相) 別

E7諸国における治験件数:サイトメガロウイルス (CMV) 網膜炎治験件数の感染症治験件数に対する比率

フェーズ (相) 別治験件数

  • フェーズ (相) 別の進行中治験件数

進捗状況別の治験件数

評価項目別の治験件数

一定期間に採用された被験者数

スポンサーの種類別治験件数

有望なスポンサー

治験主要参加企業 - サイトメガロウイルス (CMV) 網膜炎治療薬

有望な薬剤

治験プロファイルの基本情報

付録

図表

図表

List of Tables

  • Cytomegalovirus (CMV) Retinitis Therapeutics, Global, Clinical Trials by Region, 2019*
  • Cytomegalovirus (CMV) Retinitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019*
  • Cytomegalovirus (CMV) Retinitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019*
  • Cytomegalovirus (CMV) Retinitis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2019*
  • Cytomegalovirus (CMV) Retinitis Therapeutics Clinical Trials, Europe, Top Countries, 2019*
  • Cytomegalovirus (CMV) Retinitis Therapeutics Clinical Trials, North America, Top Countries, 2019*
  • Cytomegalovirus (CMV) Retinitis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2019*
  • Proportion of Cytomegalovirus (CMV) Retinitis to Infectious Disease Clinical Trials, G7 Countries (%), 2019*
  • Cytomegalovirus (CMV) Retinitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2019*
  • Cytomegalovirus (CMV) Retinitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019*
  • Proportion of Cytomegalovirus (CMV) Retinitis to Infectious Disease Clinical Trials, E7 Countries (%), 2019*
  • Cytomegalovirus (CMV) Retinitis Therapeutics, Global, Clinical Trials by Phase, 2019*
  • Cytomegalovirus (CMV) Retinitis Therapeutics, Global, Clinical Trials by Trial Status, 2019*
  • Cytomegalovirus (CMV) Retinitis Therapeutics Clinical Trials, Global, by End Point Status, 2019*
  • Cytomegalovirus (CMV) Retinitis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2019*
  • Cytomegalovirus (CMV) Retinitis Therapeutics Clinical Trials, Global, Key Sponsors, 2019*
  • Cytomegalovirus (CMV) Retinitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019*
  • Cytomegalovirus (CMV) Retinitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019*

List of Figures

  • Cytomegalovirus (CMV) Retinitis Therapeutics, Global, Clinical Trials by Region (%), 2019*
  • Cytomegalovirus (CMV) Retinitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019*
  • Cytomegalovirus (CMV) Retinitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019*
  • Cytomegalovirus (CMV) Retinitis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2019*
  • Cytomegalovirus (CMV) Retinitis Therapeutics Clinical Trials, Europe, Top Countries (%), 2019*
  • Cytomegalovirus (CMV) Retinitis Therapeutics Clinical Trials, North America, Top Countries (%), 2019*
  • Proportion of Cytomegalovirus (CMV) Retinitis to Infectious Disease Clinical Trials, G7 Countries (%), 2019*
  • Cytomegalovirus (CMV) Retinitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2019*
  • Cytomegalovirus (CMV) Retinitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019*
  • Proportion of Cytomegalovirus (CMV) Retinitis to Infectious Disease Clinical Trials, E7 Countries (%), 2019*
  • Cytomegalovirus (CMV) Retinitis Therapeutics, Global, Clinical Trials by Phase (%), 2019*
  • Cytomegalovirus (CMV) Retinitis Therapeutics, Global, Clinical Trials by Trial Status, 2019*
  • Cytomegalovirus (CMV) Retinitis Therapeutics Clinical Trials, Global, by End Point Status, 2019*
  • Cytomegalovirus (CMV) Retinitis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2019*
  • Cytomegalovirus (CMV) Retinitis Therapeutics Clinical Trials, Global, Key Sponsors, 2019*
  • Cytomegalovirus (CMV) Retinitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019*
  • Cytomegalovirus (CMV) Retinitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019*
  • GlobalData Methodology
目次
Product Code: GDHC5634CTIDB

GlobalData's clinical trial report, "Cytomegalovirus (CMV) Retinitis Global Clinical Trials Review, H1, 2019" provides an overview of Cytomegalovirus (CMV) Retinitis clinical trials scenario. This report provides top line data relating to the clinical trials on Cytomegalovirus (CMV) Retinitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

  • List of Tables
  • List of Figures
  • Report Guidance
  • GlobalData Clinical Trials Report Coverage
  • Clinical Trials by Region
  • Clinical Trials and Average Enrollment by Country
  • Clinical Trials by G7 Countries: Proportion of Cytomegalovirus (CMV) Retinitis to Infectious Disease Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Cytomegalovirus (CMV) Retinitis to Infectious Disease Clinical Trials
  • Clinical Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
  • Top Companies Participating in Cytomegalovirus (CMV) Retinitis Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profile Snapshots
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source